Sunday, September 23, 2012 8:26:56 PM
It just reversed split last November to around 2.5 million shares and pretty much ceased operations. Now with the bio-tech they have ramped up operations. Shares are already double. Please tell me how the bio-tech which most likely never gets to market and won't produce a dime of revenue for years gets funded? Bio-techs take huge amounts of cash for research and trials. Those like myself who owned IGSM prior to the reverse have seen this all before.
Recent MDXL News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 12:31:17 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 02:57:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/05/2025 08:05:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2025 06:30:43 PM
